Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,268,585,398
-
Total 13F shares
-
870,738,435
-
Share change
-
+20,271,504
-
Total reported value
-
$68,510,150,212
-
Put/Call ratio
-
80%
-
Price per share
-
$78.72
-
Number of holders
-
1,592
-
Value change
-
+$1,883,897,727
-
Number of buys
-
773
-
Number of sells
-
739
Institutional Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q3 2018
As of 30 Sep 2018,
CVS HEALTH Corp - Common Stock (CVS) was held by
1,592 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
870,738,435 shares.
The largest 10 holders included
Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BARROW HANLEY MEWHINNEY & STRAUSS LLC, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, PARNASSUS INVESTMENTS /CA, and DODGE & COX.
This page lists
1,593
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.